In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...

Derek Stefureac has run at least one marathon on all 7 seven continents — and says it helps keep the "MS symptoms at bay." ...

High-dose cholecalciferol (vitamin D) is safe and can nearly double the time it takes for clinically isolated syndrome to ...

Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a ...

New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that ...

New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term ...

During these recovery periods, also called remissions, symptoms improve partially or completely with no apparent progression of disease. However, smoldering neuroinflammation can be present from the ...

After years of caring for others, Auckland nurse Zazi Gohar faced her own health crisis when she was diagnosed with multiple ...

Starting high-efficacy monoclonal antibody therapy during childhood reduced long-term disability in pediatric-onset multiple ...

The wife of AFL great Tom Harley has spoken about her fear that her son wouldn’t survive a fight with meningococcal, urging ...